Literature DB >> 8698744

Distribution of Gs-alpha activating mutations in human thyroid tumors measured by subcloning.

V N Gorelov1, M Gyenes, F Neser, H D Röher, P E Goretzki.   

Abstract

In the search for the prevalence and distribution pattern of Gs-alpha gene mutations in differentiated thyroid tumors we examined 66 tumor tissue samples for the presence of mutations at "hot-spot" codons 201 and 227 using methods based on the polymerase chain reaction, subcloning and sequencing. The prevailing type of single-base substitution at codon 201 (71.4%) corresponded to the replacement of the wild-type sequence CGT (Arg) with TGT (Cys). The fragments of the Gs-alpha gene, including codon 201 or 227 from five follicular carcinomas and one follicular adenoma, were subcloned in Escherichia coli and it was found that the proportion of alleles with mutated codon 201 varied from 3.2% to 43%. Sequencing of the corresponding region has confirmed preliminary data indicating that the single-base changes CGT (Arg) to TGT (Cys) or CGT to CAT (His) occurred. There was only a weak correlation between the prevalence of cells bearing a mutation in the Gs-alpha gene and the level of Gs-alpha protein expression in the corresponding thyroid tumors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8698744     DOI: 10.1007/bf01187156

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  15 in total

1.  Identification of a mutation in the gene encoding the alpha subunit of the stimulatory G protein of adenylyl cyclase in McCune-Albright syndrome.

Authors:  W F Schwindinger; C A Francomano; M A Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

2.  GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours.

Authors:  C A Landis; S B Masters; A Spada; A M Pace; H R Bourne; L Vallar
Journal:  Nature       Date:  1989-08-31       Impact factor: 49.962

3.  Increased stimulatory G protein in neoplastic human thyroid tissues.

Authors:  A E Siperstein; R A Miller; C Landis; H Bourne; O H Clark
Journal:  Surgery       Date:  1991-12       Impact factor: 3.982

4.  Overexpression of Gs alpha subunit in thyroid tumors bearing a mutated Gs alpha gene.

Authors:  V N Gorelov; K Dumon; N S Barteneva; D Palm; H D Röher; P E Goretzki
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

Review 5.  ras oncogenes in human cancer: a review.

Authors:  J L Bos
Journal:  Cancer Res       Date:  1989-09-01       Impact factor: 12.701

6.  A method to increase the sensitivity of mutation specific oligonucleotide hybridization using asymmetric polymerase-chain reaction (PCR).

Authors:  V N Gorelov; H D Röher; P E Goretzki
Journal:  Biochem Biophys Res Commun       Date:  1994-04-15       Impact factor: 3.575

7.  gsp mutations in human thyroid tumours.

Authors:  H G Suarez; J A du Villard; B Caillou; M Schlumberger; C Parmentier; R Monier
Journal:  Oncogene       Date:  1991-04       Impact factor: 9.867

8.  A mutation that prevents GTP-dependent activation of the alpha chain of Gs.

Authors:  R T Miller; S B Masters; K A Sullivan; B Beiderman; H R Bourne
Journal:  Nature       Date:  1988-08-25       Impact factor: 49.962

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  Mutational activation of RAS and GSP oncogenes in differentiated thyroid cancer and their biological implications.

Authors:  P E Goretzki; J Lyons; S Stacy-Phipps; W Rosenau; M Demeure; O H Clark; F McCormick; H D Röher; H R Bourne
Journal:  World J Surg       Date:  1992 Jul-Aug       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.